Sim&Cure Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
60
- Latest Deal Type
-
Later Stage VC
- Investors
-
6
Sim&Cure General Information
Description
Developer of a patient-specific device designed to secure the treatment of a cerebral aneurysm. The company's device is fast and has optimal sizing, virtually evaluates the final position of different sizes and shapes of intracranial implants, and secures the treatment, enabling neurologists to effectively treat patients with neurovascular disorders.
Contact Information
Website
www.sim-and-cure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Education and Training Services (B2B)
Other Healthcare Technology Systems
Primary Office
- 95 rue Pierre Flourens, Bâtiment H
- 34090 Montpellier
- France
+33 09 00 00 00 00
Sim&Cure Timeline
Sim&Cure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 01-Jan-2022 | 00.000 | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series A) | 23-May-2019 | 00.000 | 00.000 | 0000 | Completed | Generating Revenue |
| 4. Early Stage VC | 17-Dec-2015 | 00000 | 00000 | 00.000 | Completed | Generating Revenue |
| 3. Accelerator/Incubator | 01-Jan-2015 | 00000 | 00000 | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | $6.56K | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jan-2013 | $6.56K | $6.56K | Completed | Generating Revenue |
Sim&Cure Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Shares | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Ordinary | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Sim&Cure Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a patient-specific device designed to secure the treatment of a cerebral aneurysm. The company's device is
Other Devices and Supplies
Montpellier, France
60
As of 2022
00.000
0000000000 0
00.000
000000
ore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation u
00000000 0000000
Rancho Santa Margarita, CA
0000
As of 0000
000.00
00000000000
000.00
0000 0
et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et d
0000000000 000000000
Chelmsford, MA
0000
As of 0000
000.00
0000000000
Add Comparison
Sim&Cure Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Applied Medical Resources | Formerly VC-backed | Rancho Santa Margarita, CA | 0000 | 000.00 | 00000000000 | 000.00 |
| 0000 0000000 | Corporate Backed or Acquired | Chelmsford, MA | 0000 | 000.00 | 0000000000 | |
| 0000000 0000 | Private Debt Financed | Knittlingen, Germany | 000 | 000000000 - | ||
| 00000 0000 | Venture Capital-Backed | Shelton, CT | 000 | 00000 | 00000000000 | 00000 |
| 0000000 | Formerly PE-Backed | Laguna Hills, CA | 000 | 00000 | 000000000 | 00000 |
Sim&Cure Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sim&Cure Patents
Sim&Cure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020365500-A1 | Simulation of the deformation after implantation of an implantable medical device | Pending | 18-Oct-2019 | 000000000 | |
| EP-4046166-A1 | Method for simulating the deformation, after implantation, of an implantable medical device | Pending | 18-Oct-2019 | 000000000 | |
| FR-3102288-A1 | Simulation of the deformation after implantation of an implantable medical device | Pending | 18-Oct-2019 | 000000000 | 0 |
| US-20220367047-A1 | Method for simulating the deformation, after implantation, of an implantable medical device | Pending | 18-Oct-2019 | 000000000 | |
| AU-2018392163-A1 | Method for determining the positioning in deployed position of an implantable medical device after expansion in a vascular structure | Pending | 19-Dec-2017 | G16H20/40 |
Sim&Cure Executive Team (6)
Sim&Cure Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alain Bonafe | Self | Board Member | 000 0000 |
| Alexis Frentz | Elaia Partners | Board Observer | 000 0000 |
| Daniel Pilaud Ph.D | IT-Translation | Board Member | 000 0000 |
| Gonzague Issenmann | Self | Board Member | 000 0000 |
| Jean-Nicolas Vernin | Self | Board Member | 000 0000 |
Sim&Cure Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Sim&Cure Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| NeuroTechnology Investors | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Elaia Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| IT-Translation | Venture Capital | Minority | 000 0000 | 000000 0 | |
| i-Lab LUISS | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Languedoc Roussillon Incubation | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |